Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural and Thermodynamic Discrimination between Agonists and Antagonists of Retinoic Acid Receptor γ and the Vitamin D Receptor.

Journal of chemical information and modeling·2026
Same author

Switching cation selectivity <i>via</i> steric tuning in sumanene-based receptors.

Chemical communications (Cambridge, England)·2026
Same author

Systemic toxicity and immunotoxicity studies of glucose oxidase-loaded extracellular vesicles derived from lung cancer cells.

Frontiers in immunology·2026
Same author

Magnetic thermoradiotherapy for lung cancer: evaluation in A549-based preclinical models.

Frontiers in oncology·2026
Same author

Axial Chirality Induction in Ferrocene-Amino Acid Hybrids─toward Chiral Redox-Active Building Blocks.

Inorganic chemistry·2026
Same author

Ag-TiO<sub>2</sub> photocatalyst for the degradation of isoprinosine: influence of silver modification on solar photocatalytic activity.

Environmental science and pollution research international·2026

Related Experiment Video

Updated: Jun 24, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

680

Surface-Bioengineered Extracellular Vesicles Seeking Molecular Biotargets in Lung Cancer Cells.

Agata Kowalczyk1, Damian Dziubak1,2, Artur Kasprzak3

  • 1Faculty of Chemistry, University of Warsaw, Pasteura Str. 1, Warsaw PL-02-093, Poland.

ACS Applied Materials & Interfaces
|June 13, 2024
PubMed
Summary

Researchers engineered extracellular vesicles (EVs) with a peptide (PTHTRWA) to target lung cancer cells. These modified EVs, carrying nanoparticles, successfully reached tumors in mice and showed no toxicity, paving the way for advanced cancer therapies.

Keywords:
NUDE miceextracellular vesicle bioengineeringlung cancer cellsmodel lipid membranepreclinical safety

More Related Videos

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
10:33

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

1.3K
Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.0K

Related Experiment Videos

Last Updated: Jun 24, 2025

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

680
An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
10:33

An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue

Published on: February 3, 2023

1.3K
Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

11.0K

Area of Science:

  • Oncology
  • Biotechnology
  • Nanomedicine

Background:

  • Personalized medicine offers novel approaches in oncology.
  • Extracellular vesicles (EVs) derived from lung cancer cells show potential as advanced therapy medicinal products.
  • Targeted drug delivery systems are crucial for effective cancer treatment.

Purpose of the Study:

  • To functionalize EVs with a lung cancer-targeting peptide (PTHTRWA) for enhanced cancer therapy.
  • To evaluate the targeting efficacy and safety of engineered EVs in preclinical models.

Main Methods:

  • EVs were functionalized with the heptapeptide PTHTRWA at C- or N-terminal ends.
  • In vitro studies used lipid membrane models and lung cancer cells (A549) and normal cells (BEAS-2B).
  • In vivo studies involved MRI tracking of SPIO-loaded EVs in tumor-bearing mice, alongside molecular dynamics and safety assays.

Main Results:

  • Functionalized EVs demonstrated specific binding to lung cancer cells.
  • MRI confirmed that engineered EVs loaded with SPIO nanoparticles successfully reached tumors after intravenous administration in mice.
  • In silico studies revealed high affinity of PTHTRWA to α5β1 integrin.
  • Preclinical safety assessments showed no cytotoxic or genotoxic effects of the engineered EVs.

Conclusions:

  • EVs functionalized with PTHTRWA can be effectively engineered for targeted lung cancer therapy.
  • The engineered EVs exhibit promising tumor-homing capabilities and a favorable safety profile.
  • This approach holds potential for developing advanced medicinal products in personalized oncology.